Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
1 other identifier
observational
400
1 country
1
Brief Summary
assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma. Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2024
CompletedFirst Submitted
Initial submission to the registry
January 29, 2024
CompletedFirst Posted
Study publicly available on registry
February 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 5, 2025
March 1, 2025
1.9 years
January 29, 2024
March 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation
Correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma.
At baseline (Day 0)
Study Arms (1)
Patients
patients treated at Rizzoli Institute from 1991 to 2021.
Interventions
review the medical records, radiological imaging, and histological data of these patients
Eligibility Criteria
Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2021
You may qualify if:
- Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2021
- Age ≥ 2 years
- Diagnosis of Ewing Sarcoma
- Patients with available clinical and imaging data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Itituto Ortopedico Rizzoli
Bologna, BO, 40136, Italy
Related Publications (2)
Grunewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Alava E, Kovar H, Sorensen PH, Delattre O, Dirksen U. Ewing sarcoma. Nat Rev Dis Primers. 2018 Jul 5;4(1):5. doi: 10.1038/s41572-018-0003-x.
PMID: 29977059RESULTPressman BD, Tourje EJ, Thompson JR. An early CT sign of ischemic infarction: increased density in a cerebral artery. AJR Am J Roentgenol. 1987 Sep;149(3):583-6. doi: 10.2214/ajr.149.3.583.
PMID: 3497548RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2024
First Posted
February 6, 2024
Study Start
January 25, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 5, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share